Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.34 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12762368 | 1.00 | GABRR1 (0.40) | GABRR1GABBR2GABBR1DPP7 | |
| SCHEMBL25462341 | 0.88 | FOLH1 (0.34) | GABRR1DPP7 | |
| SCHEMBL21166944 | 0.88 | FOLH1 (0.34) | GABRR1DPP7 | |
| SCHEMBL13254054 | 0.88 | FOLH1 (0.34) | GABRR1DPP7 | |
| SCHEMBL27250343 | 0.86 | FOLH1 (0.40) | — | |
| SCHEMBL13573523 | 0.86 | FOLH1 (0.40) | — | |
| SCHEMBL7604714 | 0.86 | FOLH1 (0.40) | — | |
| SCHEMBL26731701 | 0.85 | GABRR1 (0.41) | GABRR1GABBR2GABBR1DPP7 | |
| SCHEMBL757850 | 0.85 | GABRR1 (0.41) | GABRR1GABBR2GABBR1DPP7 | |
| SCHEMBL19361692 | 0.83 | TDP1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10793601-B2 | Therapeutic spalt-like transcription factor 4 (SALL4) peptide | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2020-10-06 | — | — | US | disclosed |
| US-20190218253-A1 | Therapeutic SALL4 Peptide | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218253-A1 | Therapeutic SALL4 Peptide | RBBP4, RBBP5, RB1 | GABRR1 1991/4885GABBR2 3261/4885GABBR1 3762/4885 |
| US-10793601-B2 | Therapeutic spalt-like transcription factor 4 (SALL4) peptide | RBBP4, SALL4, RBBP5 | GABRR1 1629/4885GABBR2 1388/4885GABBR1 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.